A role for CD8+ CTLs in PDT-induced anti-tumor immunity was first demonstrated by Korbelik et al., who showed that the depletion of CD8+ T cells in EMT6 mammary carcinoma model resulted in a 50% reduction in tumor clearance compared to controls [17]. The gene discussed is CD8A; the disease is neoplasm.